Medical Condition News

RSS

Shiva Biomedical, CorMedix to extend CRMD001 phase III trial in chronic kidney disease

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced it has amended its agreement with Shiva Biomedical, LLC.

6 Sep 2011

ERS urges EU to take action on chronic respiratory diseases

Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.

6 Sep 2011

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has entered into agreements with Quintiles Commercial US, Inc. and Integrated Commercialization Services, Inc. (ICS) to support the anticipated launch of EXPAREL, should it be approved by the Food and Drug Administration (FDA) later this year.

6 Sep 2011

The Arthritis Society warns Canadians to check for OA

Canadians who never have their joint pains and aches examined by a doctor could be making the problem much worse, The Arthritis Society warns.

6 Sep 2011

Bariatric surgery is cost-effective but has long-term complications

The majority of people who undergo bariatric weight-loss surgery benefit from the procedure, but long-term complications and further surgery are not uncommon, according to a UK paper on late postoperative complications in the October issue of BJS, the British Journal of Surgery.

6 Sep 2011

European Neurotech Investing & Partnering Summit to take place in Helsinki

The inaugural European Neurotech Investing & Partnering Summit takes place in Helsinki this week. It features keynotes on the state of the European neurotech industry, investor analysis, as well as company and research project presentations on next generation treatments emerging in the EU for unmet needs of brain and nervous system disorders like Alzheimer's, addiction, depression, schizophrenia, Parkinson's, Huntington's, stroke and more.

6 Sep 2011

Amakem receives €18m in Series A round of funding

Amakem NV today announced it has raised €18m with a syndicate of leading life sciences investors to advance its ophthalmology drug development portfolio and progress its lead candidate, AMA0076 for glaucoma, to clinical proof of concept.

6 Sep 2011

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company's third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.

6 Sep 2011

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world.

6 Sep 2011

AMA releases new Current Procedural Terminology codes

Friday September 2, 2011 the AMA released new Current Procedural Terminology (CPT) codes that will be reported by hospitals, physicians and ambulatory centers providing coverage for additional treatment options for cancer patients.

6 Sep 2011

Gene variants that help regulate serotonin may serve as predictor of risk for PSTD symptoms

Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.

6 Sep 2011

McMaster team demonstrates essential role of AMPK enzyme in exercise

You may think your lack of resolve to get off the couch to exercise is because you're lazy, but McMaster University researchers have discovered it may be you are missing key genes.

6 Sep 2011

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.

6 Sep 2011

Biologists reveal why men's ring fingers are longer than their index fingers

Biologists at the University of Florida have found a reason why men's ring fingers are generally longer than their index fingers - and why the reverse usually holds true for women.

6 Sep 2011

Researchers reveal mechanism behind how cells communicate

Cell communication is essential for the development of any organism. Scientists know that cells have the power to "talk" to one another, sending signals through their membranes in order to "discuss" what kind of cell they will ultimately become - whether a neuron or a hair, bone, or muscle. And because cells continuously multiply, it's easy to imagine a cacophony of communication.

6 Sep 2011

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has entered into an exclusive license agreement with the US National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications.

6 Sep 2011

Study: No big shift toward higher fatal heart attack rates after menopause in women

Contradicting the long-held medical belief that the risk of cardiovascular death for women spikes sharply after menopause, new research from Johns Hopkins suggests instead that heart disease mortality rates in women progress at a constant rate as they age.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Psychogenic non-epileptic seizures may go undiagnosed for longer in veterans

Psychogenic non-epileptic seizures may go undiagnosed for much longer in veterans compared to civilians, according to a new study published in the September 6, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

6 Sep 2011

Chondroitin sulfate decreases pain and improves hand function in patients with OA

New research shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with osteoarthritis (OA) of the hand compared with those in the placebo group. Results of the clinical trial available today in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), also report that chondroitin sulfate improves grip strength and relieves morning stiffness.

6 Sep 2011

Medical Condition News

Shiva Biomedical, CorMedix to extend CRMD001 phase III trial in chronic kidney disease

ERS urges EU to take action on chronic respiratory diseases

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

The Arthritis Society warns Canadians to check for OA

Bariatric surgery is cost-effective but has long-term complications

European Neurotech Investing & Partnering Summit to take place in Helsinki

Amakem receives €18m in Series A round of funding

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

AMA releases new Current Procedural Terminology codes

Gene variants that help regulate serotonin may serve as predictor of risk for PSTD symptoms

McMaster team demonstrates essential role of AMPK enzyme in exercise

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Biologists reveal why men's ring fingers are longer than their index fingers

Researchers reveal mechanism behind how cells communicate

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Study: No big shift toward higher fatal heart attack rates after menopause in women

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Psychogenic non-epileptic seizures may go undiagnosed for longer in veterans

Chondroitin sulfate decreases pain and improves hand function in patients with OA

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News